Skip to main content
. 2007 Sep 28;8(1):68. doi: 10.1186/1465-9921-8-68

Figure 7.

Figure 7

Effect of salmeterol or cytokine treatment for 24 hours on BDKRB2 promoter activity in Human ASM cells transfected with BDKRB2-Luciferase constructs. Human ASM cells were transfected and stimulated as described in Figure 4. Following 24 hours treatment cells were harvested and firefly luciferase was quantified. pGL4-BDKRB2-1kb-Luc2 (A), pGL4-BDKRB2-2kb-Luc2 (B), pGL4-BDKRB2-3kb-Luc2 (C), pGL4-BDKRB2-4kb-Luc2 (D) transfections. Data is normalised to the mean luciferase activity of each construct transfection treated with medium alone +/- S.E.M. (n = 5 independent experiments). Dunnett's Multiple Comparison Test (*p < 0.05, **p < 0.01).